In this episode of The Next Big Thing, Chris and Mobeen explore the cutting-edge of biotech with Ben Taylor, CFO and Chief Strategy Officer at Exscientia. Ben touches on his transition from the high-stakes world of investment banking to spearheading AI-driven drug development. Discover how generative AI is revolutionizing the search for novel drugs and reshaping the landscape of the pharmaceutical industry. Get an insider’s look at Exscientia’s pioneering approach to AI in drug discovery, and learn about the seismic shifts it’s creating in clinical trials and regulatory landscapes. This episode is a must-listen for anyone interested in the future of healthcare and the role AI plays in forging new paths to wellness.
For EU investors only:
Learn more about megatrends: https://www.wisdomtree.eu/en-gb/strategies/megatrend-etfs
